Hemiparesis after stroke Nervous System Diseases Hemiplegia
Conditions
Interventions
Post-stroke patients will be informed (via mail or personally) about the possibility of participating in the study. When they contact the study team, they will be informed about the study’s principles
Sponsors
Jagiellonian University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Independent locomotion (with or without aids) 2. Time from stroke onset not less than 6 months 3. Ability to establish logical verbal or non-verbal contact 4. Facial muscle efficiency, to maintain the mouthpiece of the measuring device
Exclusion criteria
Exclusion criteria: 1. Lack of independent locomotion 2. Time from onset less than 6 months 3. No possibility of establishing logical verbal or non-verbal contact 4. Other neurological diseases 5. Contraindications for physiotherapy, e.g. unstable coronary artery disease, resting heart rate above 100 thighs/min and less than 50, blood pressure above 160/95 or below 90/50, fever or hyperpyretic state
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Respiratory muscle strength expressed by respiratory drive variables given in units of pressure: kilopascals [kPa], measured using spirometry at the beginning of the first therapy and after the fifth. Respiratory drive variables include: 1. Occlusion pressure: P0.1 (inspiratory occlusion pressure for the first 100 ms of inspiration during calm breathing) 2. PImax (maximal inspiratory pressure) 3. PEmax (maximal expiratory pressure) 4. P0.1max (inspiratory occlusion pressure for the first 100 ms of forced breathing) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Electromyographic activity (EMG) of the auxiliary respiratory muscles (mm. scaleni, m. obliques externus, m. sternocleidomastoideus) at frequency in the range from 7 to 500 Hz. The EMG measures will be obtained during all breathing manoeuvres listed in the primary outcomes measure and expressed as a percentage of the values achieved during their maximal voluntary contractions (MVCs) measurements. EMG is examined at the beginning of the first therapy and after the fifth, at the same time as respiratory muscle strength 2. Functional status measured with the Timed Up & Go test (TUG) at the beginning of the first therapy and after the fifth | — |
Countries
Poland
Outcome results
None listed